Obtenez les faits, trouvez le meilleur et évitez la fraude
Legal Name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Période de rapport:
Jun 30, 2019
Date d\'entrée en vigueur:
Aug 14, 2019
| Sécurité |
Actions détenues / capital |
Valeur marchande |
Option |
|
AABA (021346101)
|
28,362,317 |
$1,967,494k |
|
|
SPDR S&P 500 ETF TR TR UNIT (78462F103)
|
3,647,500 |
$1,068,718k |
Put |
|
ANADARKO PETE (032511107)
|
10,465,000 |
$738,410k |
|
|
WABTEC (929740108)
|
6,568,373 |
$471,346k |
|
|
IQVIA HOLDINGS INC (46266C105)
|
2,579,011 |
$414,963k |
|
|
Array Biopharma Inc (04269X105)
|
8,500,000 |
$393,805k |
|
|
FIDELITY NATL INFO (31620M106)
|
2,842,640 |
$348,735k |
|
|
ANTHEM INC (036752103)
|
1,050,000 |
$296,321k |
|
|
CHARTER COMMUNICATIO (16119P108)
|
700,405 |
$276,786k |
|
|
GENERAL DYNAMICS (369550108)
|
1,335,214 |
$242,769k |
|
|
PLAYA HOTELS & RESOR (N70544106)
|
30,606,930 |
$235,979k |
|
|
IHS MARKIT LTD (G47567105)
|
3,604,997 |
$229,710k |
|
|
SHERWIN WILLIAMS CO (824348106)
|
465,699 |
$213,425k |
|
|
VISA INC COM CL A (92826C839)
|
1,187,779 |
$206,139k |
|
|
EQUIFAX INC (294429105)
|
1,463,779 |
$197,961k |
|
|
EQUINIX INC (29444U700)
|
383,132 |
$193,210k |
|
|
S&P GLOBAL INC (78409V104)
|
840,786 |
$191,523k |
|
|
CITRIX SYS INC (177376100)
|
1,916,051 |
$188,041k |
|
|
Booking Holdings, Inc. (09857L108)
|
97,449 |
$182,689k |
|
|
ASCENDIS PHARMA A S (04351P101)
|
1,540,000 |
$177,331k |
|
|
Facebook Inc (30303M102)
|
904,284 |
$174,527k |
|
|
ASTRAZENECA (046353108)
|
4,100,000 |
$169,248k |
|
|
MICROSOFT CORP (594918104)
|
1,257,503 |
$168,455k |
|
|
CIGNA CORP (125523100)
|
1,050,000 |
$165,428k |
|
|
Alphabet Inc (02079K107)
|
142,223 |
$153,730k |
|
|
Iovance Biotherapeutics Inc (462260100)
|
5,725,000 |
$140,377k |
|
|
TransUnion (89400J107)
|
1,672,343 |
$122,934k |
|
|
SEA LTD (81141R100)
|
3,375,000 |
$112,118k |
|
|
MIRATI THERAPEUTICS INC (60468T105)
|
995,000 |
$102,485k |
|
|
MYOKARDIA INC (62857M105)
|
2,000,000 |
$100,280k |
|
|
Acceleron Pharma Inc (00434H108)
|
2,375,000 |
$97,565k |
|
|
LIBERTY GLOBAL PLC (G5480U120)
|
3,675,974 |
$97,524k |
|
|
ZOGENIX INC (98978L204)
|
2,000,000 |
$95,560k |
|
|
ZAYO GROUP HLDGS INC (98919V105)
|
2,820,000 |
$92,806k |
|
|
Sage Therapeutics Inc (78667J108)
|
500,000 |
$91,545k |
|
|
ALIBABA GROUP HLDG LTD (01609W102)
|
500,000 |
$84,725k |
|
|
B. Riley Wealth Management, Inc. (023111206)
|
4,250,000 |
$82,408k |
|
|
ENANTA PHARMACEUTI (29251M106)
|
960,000 |
$81,005k |
|
|
ALNYLAM PHARMACEUTICALS INC (02043Q107)
|
1,100,000 |
$79,816k |
|
|
GENESEE & WYO INC (371559105)
|
775,000 |
$77,500k |
|
|
FIBROGEN INC (31572Q808)
|
1,700,000 |
$76,806k |
|
|
Sarepta Therapeutics Inc (803607100)
|
500,000 |
$75,975k |
|
|
NOVOCURE LTD (G6674U108)
|
1,200,000 |
$75,876k |
|
|
Reata Pharmaceuticals Inc. (75615P103)
|
800,000 |
$75,480k |
|
|
SPRINT CORPORATION (85207U105)
|
10,675,000 |
$70,135k |
|
|
GRIFOLS S A (398438408)
|
3,080,083 |
$64,990k |
|
|
EXELIXIS INC (30161Q104)
|
3,000,000 |
$64,110k |
|
|
GLOBAL BLOOD THERAPEUTICS IN (37890U108)
|
1,125,000 |
$59,175k |
|
|
LIBERTY GLOBAL PLC (G5480U104)
|
2,083,977 |
$56,247k |
|
|
ARROWHEAD PHARMACEUT (04280A100)
|
2,000,000 |
$53,000k |
|
|
Fate Therapeutics Inc (31189P102)
|
2,500,000 |
$50,750k |
|
|
RADIUS HEALTH INC (750469207)
|
2,043,149 |
$49,771k |
|
|
CVS HEALTH CORP (126650100)
|
822,500 |
$44,818k |
|
|
Fox Corp (35137L204)
|
1,182,500 |
$43,197k |
|
|
NXP Semiconductors NV (N6596X109)
|
430,000 |
$41,972k |
|
|
ZYMEWORKS INC (98985W102)
|
1,756,470 |
$38,642k |
|
|
FIRST DATA CORP (32008D106)
|
1,425,000 |
$38,575k |
|
|
PROGENICS PHARMACEUTICALS INCO (743187106)
|
5,543,386 |
$34,203k |
|
|
READY CAP CORP (75574U101)
|
2,243,239 |
$33,424k |
|
|
T MOBILE US INC COM USD0.00001 (872590104)
|
425,780 |
$31,567k |
|
|
FOX CORPORATION (35137L105)
|
836,400 |
$30,646k |
|
|
PTC THERAPEUTICS INC (69366J200)
|
600,000 |
$27,000k |
|
|
PTC THERAPEUTICS INC (69366JAB7)
|
24,130,000 |
$26,705k |
|
|
CRISPR Therapeutics AG (H17182108)
|
500,000 |
$23,550k |
|
|
QUOTIENT LTD COM NPV (G73268107)
|
2,500,000 |
$23,375k |
|
|
Codexis Inc (192005106)
|
1,250,000 |
$23,038k |
|
|
STEMLINE THERAPEUTICS INC (85858C107)
|
1,500,000 |
$22,980k |
|
|
SINA CORPORATION (G81477104)
|
510,000 |
$21,996k |
|
|
ZEALAND PHARMA A S (98920Y304)
|
1,000,000 |
$21,550k |
|
|
Invitae Corp (46185L103)
|
900,000 |
$21,150k |
|
|
CARA THERAPEUTICS (140755109)
|
951,326 |
$20,454k |
|
|
Voyager Therapeutics Inc (92915B106)
|
750,000 |
$20,415k |
|
|
CHEMOCENTRYX INC (16383L106)
|
2,000,000 |
$18,600k |
|
|
PROTAGONIST THERAPEUTICS INC (74366E102)
|
1,500,000 |
$18,165k |
|
|
AVROBIO INC (05455M100)
|
1,036,147 |
$16,848k |
|
|
CLOVIS ONCOLOGY INC (189464AC4)
|
18,750,000 |
$11,684k |
|
|
NanoString Technologies Inc (63009R109)
|
350,000 |
$10,623k |
|
|
Eiger Biopharmaceuticals Inc (28249U105)
|
1,000,000 |
$10,600k |
|
|
Voya Financial Inc. (929089100)
|
185,000 |
$10,231k |
|
|
Veracyte Inc (92337F107)
|
350,000 |
$9,979k |
|
|
PHASEBIO PHARMACEUTICALS INC (717224109)
|
756,961 |
$9,931k |
|
|
TWIST BIOSCIENCE CORP COM (90184D100)
|
307,055 |
$8,908k |
|
|
SAVARA INC (805111101)
|
3,475,000 |
$8,236k |
|
|
UNIQURE N.V. (N90064101)
|
100,000 |
$7,815k |
|
|
MILESTONE PHARMACEUTICALS IN (59935V107)
|
250,000 |
$6,788k |
|
|
CYCLERION THERAPEUTI (23255M105)
|
544,085 |
$6,230k |
|
|
SCTY 1 5/8 11/01/19 (83416TAC4)
|
5,500,000 |
$5,304k |
|
|
PERSONALIS INC (71535D106)
|
184,932 |
$5,021k |
|
|
PFENEX INC (717071104)
|
600,000 |
$4,044k |
|
|
SANOFI (80105N113)
|
6,827,805 |
$3,550k |
|
|
AKERO THERAPEUTICS INC (00973Y108)
|
150,000 |
$2,873k |
|
|
APTINYX INC COM (03836N103)
|
670,000 |
$2,238k |
|
|
GOSSAMER BIO INC (38341P102)
|
100,000 |
$2,218k |
|
|
ZAFGEN INC (98885E103)
|
1,800,000 |
$2,142k |
|
|
Assembly Biosciences Inc (045396108)
|
100,000 |
$1,349k |
|
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
25,000 |
$1,208k |
|
|
RADIUS HEALTH INC (750469AA6)
|
1,250,000 |
$1,132k |
|
|
Occidental Petroleum Corp (674599105)
|
20,000 |
$1,006k |
|
De nombreuses personnes ont été brûlées par des fraudes et des stratagèmes de Ponzi. Nous avons donc créé ce site Web pour vous aider, en tant qu’investisseur potentiel, à obtenir les faits, à trouver le meilleur des moyens, et à éviter la fraude et les stratagèmes de Ponzi.
Toutes les informations fournies sur ce site sont fournies sans garantie et à des fins d'information uniquement.
InvestingReview.org ne fournit pas de conseils en investissement. InvestingReview.org n'est pas un conseiller en investissement et n'est ni endossé ni affilié à un organisme de réglementation américain ou non américain.
Entreprises récemment recherchées
Remarque: les données de recherche sont accumulées par des tiers et actualisées une fois par jour.